Search research articles
Contact Us
Filters
Showing results (181-190 of 186) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 186 results.
The Lancet. Microbe
|
January 13, 2025
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials
Navin Venkatraman, Alfred B Tiono, Georgina Bowyer, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
Prachi Bhave, Tasnia Ahmed, Serigne N Lo, et al.
The Journal of Infectious Diseases
|
February 25, 2016
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01
Ruth O Payne, Kathryn H Milne, Sean C Elias, et al.
The Lancet. Infectious Diseases
|
June 16, 2024
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
Sarah E Silk, Wilmina F Kalinga, Jo Salkeld, et al.
JCI Insight
|
November 3, 2017
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
Ruth O Payne, Sarah E Silk, Sean C Elias, et al.
The New England Journal of Medicine
|
January 29, 2015
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
Katie Ewer, Tommy Rampling, Navin Venkatraman, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 186) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 186 results.
The Lancet. Microbe
|
January 13, 2025
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials
Navin Venkatraman, Alfred B Tiono, Georgina Bowyer, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
Prachi Bhave, Tasnia Ahmed, Serigne N Lo, et al.
The Journal of Infectious Diseases
|
February 25, 2016
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01
Ruth O Payne, Kathryn H Milne, Sean C Elias, et al.
The Lancet. Infectious Diseases
|
June 16, 2024
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
Sarah E Silk, Wilmina F Kalinga, Jo Salkeld, et al.
JCI Insight
|
November 3, 2017
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
Ruth O Payne, Sarah E Silk, Sean C Elias, et al.
The New England Journal of Medicine
|
January 29, 2015
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
Katie Ewer, Tommy Rampling, Navin Venkatraman, et al.
Page
of 19